Paralos Bioscience Inc. has raised $1.2M in total funding. The most recent round was Seed.
Paralos Bioscience Inc. is headquartered in Los Angeles, CA.
Paralos Bioscience, co-founded by Yanxi Yang, is developing a phage-drug conjugate platform targeting drug-resistant infections and has been backed by Carbon Silicon Ventures, Larta Institute, Incate, and UCLA's Magnify program.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.